StockDuty ← Dashboard Oct 22, 2026 02:35 PM ET
SignalCorporate

Sartorius Stedim Biotech S.A. Non-GAAP EPS of €2.84, revenue of €2.29B

Sartorius Stedim Biotech reported non-GAAP EPS of €2.84 and revenue of €2.29B.

What happened: Sartorius Stedim Biotech S.A. reported 9M Non-GAAP EPS of €2.84 and revenue of €2.29B, up 4.1% year over year. Management confirmed and partially refined its fiscal year 2026 guidance. Key numbers: 9M Non-GAAP EPS €2.84; revenue €2.29B (+4.1% Y/Y); constant currency sales growth guidance around 6 to Why it matters: Growth including intended customer compensation for U.S. tariffs is expected in the lower half of the range, while operational growth excluding tariff effects is expected near the midpoint. The capex ratio guidance was refined slightly below the prior-year level. Coverage: 4 outlets in 24h
Sartorius Stedim Biotech S.A. reported 9M Non-GAAP EPS of €2.84 and revenue of €2.29B, up 4.1% year over year. Management confirmed and partially refined its fiscal year 2026 guidance.
Growth including intended customer compensation for U.S. tariffs is expected in the lower half of the range, while operational growth excluding tariff effects is expected near the midpoint. The capex ratio guidance was refined slightly below the prior-year level.
Sources